Mecamylamine-precipitated nicotine-withdrawal aversion in rats

European Journal of Pharmacology
T SuzukiM Misawa

Abstract

The present study examined a rapid and convenient model for evaluating nicotine dependence using the conditioned place preference paradigm. Rats were chronically infused subcutaneously with 9 mg/kg per day nicotine using an osmotic minipump. After nicotine infusion for 7 days, the nicotinic receptor antagonist mecamylamine produced a place aversion in nicotine-dependent rats, but not in acute nicotine-treated rats or sham-operated rats. These results suggest that the mecamylamine-precipitated withdrawal aversion in rats chronically treated with nicotine may result from physical dependence on nicotine, and may be useful for studying the physical dependence on nicotine.

References

Apr 1, 1978·Pharmacology, Biochemistry, and Behavior·D J Sanger
May 1, 1990·Pharmacology, Biochemistry, and Behavior·B CostallM B Tyers
Jan 1, 1989·Life Sciences·M E CarrollR M Keenan
Feb 1, 1985·Pharmacology, Biochemistry, and Behavior·P J FudalaE T Iwamoto
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·F O Risinger, R A Oakes
Jan 1, 1993·Psychopharmacology·D H MalinO B Wilson
Mar 1, 1996·Pharmacology, Biochemistry, and Behavior·Y K FungY S Lau

❮ Previous
Next ❯

Citations

Apr 24, 2007·Neurotoxicity Research·Neil E Paterson, Athina Markou
Jun 30, 2005·Psychopharmacology·Benoît ForgetMarie-Hélène Thiébot
Sep 16, 2005·Psychopharmacology·David H MalinBarbara A Perales
Oct 14, 2010·Psychopharmacology·Michael J McCarthyMaria Hadjiconstantinou
May 21, 2013·Neuropharmacology·Laura E O'Dell, Oscar V Torres
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·P J Kenny, A Markou
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·D H Malin
Aug 26, 1998·Drug and Alcohol Dependence·M R Picciotto
Aug 28, 2001·Alcohol·H Miyata, T Yanagita
Apr 24, 2003·Behavioral Neuroscience·Joyce Besheer, Rick A Bevins
Aug 3, 2002·The European Journal of Neuroscience·Eleni T TzavaraGeorge G Nomikos
Mar 6, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·David H MalinAli Fattom
May 3, 2008·The Journal of Pharmacology and Experimental Therapeutics·Lisa L MerrittM Imad Damaj
Jan 28, 2004·Annual Review of Psychology·Timothy B BakerLaurie Chassin
Oct 6, 2005·Psychopharmacology·Bernard Le Foll, Steven R Goldberg
Mar 29, 2011·Annual Review of Neuroscience·Mariella De Biasi, John A Dani
May 2, 2012·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Edwin A Bergin, Ewine F van Dishoeck
Nov 27, 2010·Neuropharmacology·Maria Hadjiconstantinou, Norton H Neff
Jan 6, 2009·Pharmacology, Biochemistry, and Behavior·Laura E O'Dell, Taline V Khroyan
Nov 19, 2004·The European Journal of Neuroscience·Graciela N BalerioRafael Maldonado
May 28, 2010·Synapse·Maria HadjiconstantinouNorton H Neff
Jan 12, 2000·Brain Research·R IsolaM Hadjiconstantinou
Dec 21, 2005·European Journal of Pharmacology·Gökhan GöktalayWilliam R Millington
Jul 26, 2011·Biochemical Pharmacology·Michael Paolini, Mariella De Biasi
Mar 25, 2011·Biological Psychiatry·Daniel Scott, Noboru Hiroi
Nov 30, 2014·Neuropharmacology·K J JacksonM I Damaj
May 22, 2010·Neuroscience and Biobehavioral Reviews·Amanda Hudson, Jennifer A Stamp
Dec 19, 2006·Pharmacology, Biochemistry, and Behavior·Carrie E Wilmouth, Linda P Spear
Mar 26, 2008·Synapse·Raffaella IsolaMaria Hadjiconstantinou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.